Tyson's New CEO Buries Genetics and Sells 'Best Cost' — While Chicken Quietly Guides Down
Jeff Schomburger's first call reframes the whole company around cost and brands, drops the genetics story that once carried a $9–10/share pitch, and asks investors to wait two years
TSN · Earnings Call · 2026-11-16
A new vocabulary for an old company
Jeff Schomburger has held the CEO seat for about two months, and he used his first Tyson earnings call to do something the company hasn't done since 2022: replace its entire strategic vocabulary. The phrase best cost is now the top-ranked theme in Tyson's keyword record — with essentially no prior history at the company — and it anchors a three-part framework: be consumer-preferred, be indispensable to customers as "One Tyson," and win through best cost, defined carefully as "the lowest cost to make the product consumers and customers prefer in every tier."
Our innovation success rate is not where it needs to be. We show up to our largest customers as 3 companies, not one. It will take 1 or 2 years to show fully in results, and I'd rather tell you that now.
The self-critique is unusually blunt for a debut, and it is paired with a new incentive architecture — household penetration, blind-taste preference, shelf space and shopability are being pushed "BU by BU, function by function" into the enterprise scorecard. The setup line is that best cost funds brands, brands build customer scale, customer scale fills plants. It is a coherent loop, and it is also a promise whose payoff management explicitly dates to fiscal 2028.
The underlying year was decent: adjusted operating income of $1.98 billion and EPS of $3.44, with Prepared Foods at a record $1.33 billion and Chicken earning $1.86 billion "in a year when industry prices fell." Beef lost $654 million. But the raw fundamentals show how thin the cushion is — operating income of $362 million in the latest filed quarter, up 39% year-over-year, on a gross margin of 6.6%, down 1.6 percentage points.
What Tyson stopped talking about
The loudest signal on this call is an absence. Genetics was the single biggest keyword in Tyson's Q2 2026 call and the second biggest in Q3 — the prior CEO spent multiple analyst exchanges explaining how a new big-bird breed would flow through live operations, and attached a valuation to it.
“That genetics business, for example, that I listed earlier, sitting inside Chicken, genetics companies trade at 20%, 25% -- 20x, 25x... That's worth about $9, $10 a share to Tyson.” — Donnie King, President and Chief Executive Officer · 2026-05-04
On this call, genetics comes up once, in passing, in answer to a question about guidance assumptions. That is a theme being quietly retired — or at least de-rated from narrative centerpiece to operating detail. It matters because the same quarter contained the other half of the story: Chicken guidance steps down from $1.86 billion to $1.3–1.6 billion for fiscal 2027 on industry supply growth and higher grain. The insulation thesis that dominated 2026 — that Tyson is "not a commodity chicken company" — is still asserted, but the number no longer cooperates.
“A very small amount of our chicken... it's less than 1% of our chicken meat actually ends up being sold on the commodity market.” — Wes Morris, Chief Operating Officer · 2026-11-16
That is a genuine structural point. It is also true that commodity pressure walked Chicken guidance down by roughly $300 million at the midpoint anyway. Insulated is not immune, and the prior call's framing — “I don't think about Tyson as a commodity chicken company. About 3/4 of our Chicken segment's operating income now runs on the same model as Prepared Foods” — Donnie King, President and Chief Executive Officer · 2026-08-03 — reads, in hindsight, as a claim the market is now being asked to re-test.
Beef is the swing, and the swing is control
Beef guidance of a $300 million loss to $100 million of profit against a $654 million loss is the single biggest driver of the fiscal 2027 range. Management is leaning hard on network optimization: three advantaged facilities in the cattle belt, the Amarillo second shift reopening by summer 2027, and a new Allied Beef supply partnership. COO Wes Morris split the improvement "roughly 50-50" between things Tyson controls and the network work — a useful tell that half the beef recovery is self-help, not a cattle-cycle gift. Packer margins are improving off deeply negative levels, but Morris warned heifer retention will tighten supply near term before it helps.
Notably absent from the global theme set: nothing in the market-level keyword tape maps to Tyson's protein story. No network optimization-style wave is being ridden here; this is a company-specific execution bet, not a sector tide.
The number investors will argue about
Prepared Foods is the awkward one. It grew segment operating income 5.5% to $1.33 billion and gained volume share in 45 of 52 weeks — yet guides to $1.25–1.4 billion, essentially flat at the midpoint. Andrew Strelzik asked the question everyone was thinking: “The profit guidance is basically flat at the midpoint year-over-year. So has your underlying view of the Prepared Foods outlook changed?” — Andrew Strelzik, Analyst · 2026-11-16 The answer involved grain headwinds in turkey, higher MAP investment, and a pledge not to chase share with price. A record year guiding flat is not a disaster — it is a discipline statement, and it is being made deliberately.
Balance sheet buys the patience
The reason management can ask for two years is the capital structure. Effective net cash of -$5.75 billion supports net debt-to-adjusted EBITDA of 2.1x, with $4.1 billion of liquidity and interest coverage of 3.7x. Tyson returned $1.1 billion to shareholders in fiscal 2026, including $427 million of buybacks, added $93 million more in Q1 2027, and raised the dividend 2% for a 15th consecutive year.
The tension in one line: a brand-new CEO, a brand-new lexicon, a record Prepared Foods year guiding flat, a Chicken segment guiding down, and a Beef segment where half the recovery is promised self-help. The market gave the stock a 10% run into the print. Fiscal 2027 is the year that run gets audited — and the thing to watch is not whether "best cost" appears again, but whether genetics and high attribute brands start showing up in the numbers rather than the slides.